Smoking weed may actually keep us all from going crazy.

At least that appears to be the consensus of a recent study published in the November edition of the journal Neuropsychopharmacology, which finds that cannabidiol, the non-psychoactive compound in marijuana, provides just as much relief from the symptoms of psychosis as conventional methods.

During a recent study, researchers from the Netherlands and the UK observed 42 patients suffering from schizophrenia and acute paranoia that were treated with both CBD and a common anti-psychotic medication called Amisulpride. While both treatments appeared to provide “equally significant clinical improvement,” those patients treated with CBD experienced fewer adverse effects. Scientists say their findings show that CBD could prove to be a cheaper, safer and more tolerable alternative to current anti-psychotic treatments.

“The use of antipsychotic drugs is associated with frequent side effects, which markedly influence acute compliance and long-term treatment adherence. These include motor disturbances, weight gain and sexual dysfunction. Compared with Amisulpride, we found that treatment with cannabidiol was associated with significantly fewer extrapyramidal symptoms, less weight gain, and lower prolactin increase—a predictor of galactorrhoea and sexual dysfunction. Furthermore, cannabidiol was well-tolerated and did not significantly affect hepatic or cardiac functions.”

While researchers believe their findings provide evidence that suggests marijuana-based medication could one day be used to treat schizophrenia, some American medical professionals disagree, stating that smoking weed is more of a cause than a cure.

Earlier this month, a study published in the journal Schizophrenia Bulletin stated that young people that smoke marijuana might have a greater tendency to develop mental disorders later in life. However, there is still no evidence, or even a cleverly constructed piece of propaganda that leads non-biased medical experts to believe that pot smoking leads to schizophrenia.